Search - tctmd.com

Displaying 41 - 60 of 351

Sort: Relevancy | Date

News Daily News

Good News for CV Recovery After COVID-19 Vaccine Myocarditis

Yael L. Maxwell

August 29, 2024

News Daily News

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Yael L. Maxwell

August 16, 2024

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

News Daily News

Survival After Bystander CPR in OHCA Varies by Race/Ethnicity, Sex

Caitlin E. Cox

August 12, 2024

News Daily News

FDA to Add New Diversity Requirements for Certain Clinical Studies

Todd Neale

July 15, 2024

News Daily News

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

Yael L. Maxwell

July 10, 2024

News Daily News

ECG Abnormalities on Routine Screening Tied to CVD Events in Large Study

Todd Neale

July 05, 2024

News Daily News

Despite Gains, Black Americans Still Face Higher CV Mortality

Yael L. Maxwell

June 19, 2024

News Daily News

ChatGPT Can Pass Clinical Exams Like a Fellow, but With Some Caveats

L.A. McKeown

May 20, 2024

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Michael O'Riordan

May 13, 2024

News Conference News SCAI 2024

AI Picks Up on Info Operators Miss on Angiograms: AI-ENCODE

L.A. McKeown

May 03, 2024

News Daily News

Poor Sleep Quality Linked to CVD Events and Mortality

Yael L. Maxwell

April 25, 2024

News Daily News

Data Fail to Support Link Between COVID-19 Vaccines and SCD in Young People

Todd Neale

April 19, 2024

News Conference News ACC 2024

HUDDLE Up! High BP and Cardiac Changes Prevalent in Retired NFL Players

Michael O'Riordan

April 15, 2024

News Conference News ACC 2024

Lack of Sleep Ups Hypertension Risk, Especially for Women

Yael L. Maxwell

April 03, 2024

News Daily News

FDA Approves Aprocitentan for Inadequately Controlled Hypertension

Michael O'Riordan

March 20, 2024

News Conference News THT 2024

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

Michael O'Riordan

March 11, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Michael O'Riordan

February 08, 2024

News Daily News

Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details

Michael O'Riordan

January 25, 2024

Advertisement

Good News for CV Recovery After COVID-19 Vaccine Myocarditis

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Survival After Bystander CPR in OHCA Varies by Race/Ethnicity, Sex

FDA to Add New Diversity Requirements for Certain Clinical Studies

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

ECG Abnormalities on Routine Screening Tied to CVD Events in Large Study

Despite Gains, Black Americans Still Face Higher CV Mortality

ChatGPT Can Pass Clinical Exams Like a Fellow, but With Some Caveats

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

AI Picks Up on Info Operators Miss on Angiograms: AI-ENCODE

Poor Sleep Quality Linked to CVD Events and Mortality

Data Fail to Support Link Between COVID-19 Vaccines and SCD in Young People

HUDDLE Up! High BP and Cardiac Changes Prevalent in Retired NFL Players

Lack of Sleep Ups Hypertension Risk, Especially for Women

FDA Approves Aprocitentan for Inadequately Controlled Hypertension

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content